(Q48148963)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428071%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

title

Brains of aged apolipoprotein E-deficient mice have increased levels of F2-isoprostanes, in vivo markers of lipid peroxidation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428071%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428071%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

D Praticò

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428071%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

R K Tangirala

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428071%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

language of work or name

English

0 references

publication date

1 August 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428071%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neurochemistry

10 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428071%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428071%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428071%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

736-741

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428071%20AND%20SRC:MED&resulttype=core&format=json

Behavioural, physiological and morphological analysis of a line of apolipoprotein E knockout mouse.

10 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

Aging, energy, and oxidative stress in neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

Transgenic mouse models of lipoprotein metabolism and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

Evidence for normal aging of the septo-hippocampal cholinergic system in apoE (-/-) mice but impaired clearance of axonal degeneration products following injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

The measurement and mechanism of lipid peroxidation in biological systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

DNA oxidation matters: the HPLC-electrochemical detection assay of 8-oxo-deoxyguanosine and 8-oxo-guanine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

Reduced levels of antioxidants in brains of apolipoprotein E-deficient mice following closed head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

Oxidative stress hypothesis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

Neurodegeneration in the central nervous system of apoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

Increased 3-nitrotyrosine in brains of Apo E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

The isoprostanes. Current knowledge and directions for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

Isoprostanes: potential markers of oxidant stress in atherothrombotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

Apolipoprotein E polymorphism and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

Generation of 8-epiprostaglandin F2alpha by human monocytes. Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

Localization of distinct F2-isoprostanes in human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

IPF2alpha-I: an index of lipid peroxidation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

Nomenclature of isoprostanes: a proposal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

On the metabolism of apolipoprotein E and the Alzheimer diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

Apolipoprotein E and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

Frequency of the apolipoprotein E epsilon 2 allele is diminished in sporadic Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X

Phosphorylation of tau protein is not affected in mice lacking apolipoprotein E

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730736.X